Advertisement
U.S. Markets closed

Pila Pharma AB (publ) (PILA.ST)

Stockholm - Stockholm Real Time Price. Currency in SEK
4.6700-0.1300 (-2.71%)
At close: 04:55PM CET
Currency in SEK

Valuation Measures4

Market Cap (intraday) 130.21M
Enterprise Value 127.66M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)110.45
Price/Book (mrq)50.57
Enterprise Value/Revenue 123.46
Enterprise Value/EBITDA -2.56

Trading Information

Stock Price History

Beta (5Y Monthly) 0.45
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 39.2000
52 Week Low 31.0000
50-Day Moving Average 35.1602
200-Day Moving Average 33.6880

Share Statistics

Avg Vol (3 month) 377.68k
Avg Vol (10 day) 325.37k
Shares Outstanding 527.13M
Implied Shares Outstanding 6N/A
Float 814.9M
% Held by Insiders 139.81%
% Held by Institutions 10.02%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Jun 30, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-597.80%

Management Effectiveness

Return on Assets (ttm)-108.13%
Return on Equity (ttm)-276.40%

Income Statement

Revenue (ttm)1.05M
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)13.50%
Gross Profit (ttm)N/A
EBITDA -5.8M
Net Income Avi to Common (ttm)-6.92M
Diluted EPS (ttm)-0.2500
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)2.54M
Total Cash Per Share (mrq)0.11
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)1.47
Book Value Per Share (mrq)0.11

Cash Flow Statement

Operating Cash Flow (ttm)-4.96M
Levered Free Cash Flow (ttm)-2.37M